<?xml version="1.0" encoding="UTF-8"?>
<list list-type="simple">
 <list-item>
  <label>1. </label>
  <p>Large-volume, extensively-characterized HIV-positive samples, including serial specimens from seroconverters and patients with particularly early ART initiation;</p>
 </list-item>
 <list-item>
  <label>2. </label>
  <p>Baseline samples from individuals starting PrEP and serial samples collected while on and after stopping PrEP, including from documented and potential PrEP-breakthrough infections;</p>
 </list-item>
 <list-item>
  <label>3. </label>
  <p>Chronic viremics (i.e. not virally suppressed even with longstanding infection)</p>
 </list-item>
 <list-item>
  <label>4. </label>
  <p>Elite controllers (i.e. continuously virally suppressed despite not having been treated)</p>
 </list-item>
</list>
